The DOI matches its Crossref record; 12 of the 12 references it cites were found in a registry or an index.
Infective Endocarditis—A Prospective Study at the End of the Twentieth Century: New Predisposing Conditions, New Etiologic Agents, and Still a High Mortality
Abstract
Introduction Abbreviations used in this article: IE, infective endocarditis, IVDU, intravenous drug users, TEE, transesophageal echocardiography, TTE, transthoracic echocardiography. Despite great medical progress, infective endocarditis (IE) remains a serious infection that affects a great number of patients each year (7,28,67). During the last 2 decades, profound changes have taken place in susceptible populations, distribution of responsible microorganisms, accuracy of diagnostic techniques, and procedures for medical management (54,58,62). Transesophageal echocardiography (TEE) has become the leading tool for the diagnosis of IE (5,52,59), and new diagnostic criteria were proposed in 1994 (16). Nowadays, intravenous drug users (IVDU) are the group at greatest risk of acquiring IE (57). Although often these patients are human immunodeficiency virus (HIV)-positive, to date there are few studies describing the role that HIV infection plays in the course of IE (50,66). Many series do not fully reflect these changes because they were either retrospective, collected over a long period of time, or both (22,23,46,49,55,68,69). We conducted a prospective study with the aim of describing the incidence, place of acquisition, population involved, etiologic agents, diagnosis, and outcome of cases with IE in a large teaching institution. We focused particularly on those episodes that affected HIV-infected patients and nosocomially acquired cases in order to describe specific characteristics in these populations. The size and characteristics of our institution (Hospital General Universitario “Gregorio Marañón,” Madrid, Spain) permitted the collection of a large, unselected series of IE in a short period of time, which in our view reflects the major changes in the features of IE at the beginning of the present century. Methods Our institution is a 1,750-bed tertiary teaching hospital serving an urban area of approximately 650,000 inhabitants. It has an active program of solid organ (renal, hepatic, and cardiac) transplantation and has specific units for infectious diseases, oncology, hematology, and intensive care medicine. The cardiology and cardiovascular services are closely related to the infectious diseases unit by a program of consulting service. Study period: From March 1994 to October 1996 all cases of IE were prospectively followed by an infectious diseases consultant. Inclusion criteria: Cases included in the study fulfilled 1 or more of the following criteria: 1) Clinical suspicion of IE. von Reyn (69), Steckelberg (59), and Durack (16) diagnostic criteria were employed. A case was included if it was accepted by 1 of the sets of criteria. (Steckelberg et al published a series of IE in 1991 in which they proposed a revised version of von Reyn’s criteria for IE. Steckelberg’s classification was simpler than von Reyn’s, but it is not the most commonly used in clinical practice today. Nevertheless we included it in our study in order to compare all available classifications.) 2) Echocardiographic evidence of IE. Cases that presented valvular vegetations, new prosthesis dehiscence, valve insufficiency, and perivalvular abscesses in an appropriate clinical setting were evaluated. 3) All patients with bloodstream infections caused by Streptococcus viridans, Streptococcus bovis, HACEK group micro-organisms, Staphylococcus aureus or Enterococcus spp. were prospectively screened. Special attention was paid to patients with primary bacteremia, mainly if they were IVDU or patients with prosthetic valves. 4) Histologic findings of IE. Protocol: From each episode the following data were collected: Epidemiologic features (sex, age, underlying conditions, previous heart diseases, comorbidity according to the Charlson index [11] and invasive procedures during the previous 3 months); clinical characteristics (affected valve, signs and symptoms); laboratory and microbiologic results (isolates, susceptibility tests, and serology results if available); X-ray and echocardiographic findings; complications; treatment; and outcome. Definitions: Acute renal failure: an increase in the serum creatinine level to >2.0 mg/dL from a baseline level of <1.2 mg/dL or the need for hemodialysis. Fever: 2 or more axillary temperatures >38 °C. (Axillary temperature is the most commonly used in clinical practice in Spain; it is simple and not invasive and avoids cross-contamination related to rectal or oral sampling.) Right-sided involvement: tricuspid or pulmonary valves affected on echocardiography or the presence of a new murmur and pulmonary embolism. Left-sided involvement: mitral or aortic valves affected on echocardiography or a new murmur in a patient with previous left-sided valve disease and/or systemic embolism (central nervous system, spleen, extremities). Nosocomial IE: the presence of IE more than 72 hours after admission linked to an invasive inhospital procedure or during the 8 weeks after discharge. (Most authors include as nosoc
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Infective Endocarditis: An Analysis Based on Strict Case Definitions
VON REYN, C. F., LEVY, B. S., ARBEIT, R. D., FRIEDLAND, G., & CRUMPACKER, C. S. (1981) · Annals of Internal Medicine · doi:10.7326/0003-4819-94-4-505 · Cited by 775
Daniel, W. G., Mügge, A., Martin, R. P., Lindert, O., Hausmann, D., Nonnast-Daniel, B., Laas, J., & Lichtlen, P. R. (1991) · New England Journal of Medicine · doi:10.1056/nejm199103213241203 · Cited by 723
Systemic Infection Related to Endocarditis on Pacemaker Leads: Clinical Presentation and Management
Klug, D., Lacroix, D., Savoye, C., Goullard, L., Grandmougin, D., Hennequin, J. L., Kacet, S., & Lekieffre, J. (1997) · Circulation · doi:10.1161/01.cir.95.8.2098 · Cited by 593
Heldman, A. W., Hartert, T. V., Ray, S. C., Daoud, E. G., Kowalski, T. E., Pompili, V. J., Sisson, S. D., Tidmore, W. C., vom Eigen, K. A., Goodman, S. N., et al. (1996) · The American Journal of Medicine · doi:10.1016/s0002-9343(96)00070-8 · Cited by 289
Evaluation of new clinical criteria for the diagnosis of infective endocarditis
Bayer, A. S., Ward, J. I., Ginzton, L. E., & Shapiro, S. M. (1994) · The American Journal of Medicine · doi:10.1016/0002-9343(94)90144-9 · Cited by 227
Lamas, C. C., & Eykyn, S. J. (1997) · Clinical Infectious Diseases · doi:10.1086/513765 · Cited by 188
Staphylococcus aureus Prosthetic Valve Endocarditis: Optimal Management and Risk Factors for Death
John, M. D. V., Hibberd, P. L., Karchmer, A. W., Sleeper, L. A., & Calderwood, S. B. (1998) · Clinical Infectious Diseases · doi:10.1086/516378 · Cited by 153
Negative predictive value of the Duke criteria for infective endocarditis
Dodds, G. A., Sexton, D. J., Durack, D. T., Bashore, T. M., Corey, G. R., Kisslo, J., & Service, T. D. E. (1996) · The American Journal of Cardiology · doi:10.1016/s0002-9149(97)89372-1 · Cited by 115
Stockheim, J. A., Chadwick, E. G., Kessler, S., Amer, M., Haq, N. A., Dajani, A. S., & Shulman, S. T. (1998) · Clinical Infectious Diseases · doi:10.1086/515021 · Cited by 112
Infective endocarditis: Ten-year review of medical and surgical therapy
Vlessis, A. A., Hovaguimian, H., Jaggers, J., Ahmad, A., & Starr, A. (1996) · The Annals of Thoracic Surgery · doi:10.1016/0003-4975(96)00029-x · Cited by 99
Cited by
Wilson, W., Taubert, K. A., Gewitz, M., Lockhart, P. B., Baddour, L. M., Levison, M., Bolger, A., Cabell, C. H., Takahashi, M., Baltimore, R. S., et al. (2007) · Circulation · doi:10.1161/circulationaha.106.183095 · Cited by 2,814
Guidelines on the prevention, diagnosis, and treatment of infective endocarditis (new version 2009)
Endorsed by the European Society of Clinical Microbiology and Infectious Diseases (ESCMID) and by the International Society of Chemotherapy (ISC) for Infection and Cancer, Habib, G., Hoen, B., Tornos, P., Thuny, F., Prendergast, B., Vilacosta, I., Moreillon, P., de Jesus Antunes, M., Thilen, U., et al. (2009) · European Heart Journal · doi:10.1093/eurheartj/ehp285 · Cited by 2,014
Moreillon, P., & Que, Y.-A. (2004) · The Lancet · doi:10.1016/s0140-6736(03)15266-x · Cited by 861
Infective Endocarditis Epidemiology Over Five Decades: A Systematic Review
Slipczuk, L., Codolosa, J. N., Davila, C. D., Romero-Corral, A., Yun, J., Pressman, G. S., & Figueredo, V. M. (2013) · PLoS ONE · doi:10.1371/journal.pone.0082665 · Cited by 453
Pettersson, G. B., Coselli, J. S., Pettersson, G. B., Coselli, J. S., Hussain, S. T., Griffin, B., Blackstone, E. H., Gordon, S. M., LeMaire, S. A., & Woc-Colburn, L. E. (2017) · The Journal of Thoracic and Cardiovascular Surgery · doi:10.1016/j.jtcvs.2016.09.093 · Cited by 410
Metadata
- Authors
- BOUZA, E., MENASALVAS, A., MUÑOZ, P., VASALLO, F. J., MORENO, M. D. M., & FERNÁNDEZ, M. A. G.
- Venue
- Medicine
- Published
- 2001-09
- Volume
- 80
- Issue
- 5
- Pages
- 298-307
- ISSN
- 0025-7974 (ISSN-L)
- OpenAlex
- W2043854591
- Cited by
- 177
- References
- 12
- FWCI
- 3.33
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Infective Endocarditis—A Prospective Study at the End of the Twentieth Century: New Predisposing Conditions, New Etiologic Agents, and Still a High Mortality. https://app.cochat.ai/papers/10.1097/00005792-200109000-00003
- The paper
- BOUZA, E., MENASALVAS, A., MUÑOZ, P., VASALLO, F. J., MORENO, M. D. M., & FERNÁNDEZ, M. A. G. (2001). Infective Endocarditis—A Prospective Study at the End of the Twentieth Century: New Predisposing Conditions, New Etiologic Agents, and Still a High Mortality. Medicine. https://doi.org/10.1097/00005792-200109000-00003
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.